Schedule

Time

Program

Place

April 24 2010
(Saturday)

08:00-20:00

Registration

Lobby, 1F, ECEC

April 25, 2010
(Sunday) Morning

08:20-08:40

Group Photo

The Gate of ECEC, 1F

09:00-09:35

Opening Ceremony

 

09:40-11:30

Keynote Forum

April 25, 2010
(Sunday) Evening

18:30-20:30

Welcome Banquet and Art Performance

 

 

 

 

 

April 25, 2010
(Sunday) Afternoon

13:30-17:05

Track 1-1: Molecular Oncology on Breast Cancer(Part I)

Room No. 7, 2F, ECEC

13:30-17:05

Track 1-2:  Pathology and Toxicology of Breast Cancer

Room No. 8, 2F, ECEC

13:30-17:05

Track 2-1: Gene Expression Microarrays and Recurrence Prediction

Room No. 9, 2F, ECEC

13: 30-15:10

Track 1-3: The Cancer Genomics, Epigenics and Proteomics

Room No. 11, 2F, ECEC

15:10-16:45

Track 2-2: Biomarkers in Pathway Analysis

16:45-17:45

Track 3-1: Molecular Target Validations, Drug Designs and Discovery Chemistry

13:30-15:10

Track 3-2: RNAi, microRNA, ncRNA and siRNA

Room No. 12, 2F, ECEC

15:25-17:05

Track 4-1: Molecular Diagnostics in Breast Cancer

13: 30- 14:20

Track 3-3: Bioinformatics and Computer Aided Drug Design

Room No. 16, 2F, ECEC

14:10-17:05

Track 4-2: Diagnostic Pathology and Prognostics in Breast Cancer(Part I)

13:30-15:10

Track 5-1: Adjuvant Chemotherapy and Adjuvant Targeted Therapy

 

Room No. 18, 2F, ECEC

15:25-17:05

Track 5-2: Tailored Radiation Therapy for Breast Cancer Stages

April 26, 2010
(Monday) Morning

08:30-11:15

Track 1-4: Epidemiology, Genetics and Prevention(Part I)

 

Room No. 7, 2F, ECEC

11:15-11:40

Track 5-3: Advanced Chemotherapy

08:30-10:45

Track 1-5: Immunology and Immunotherapy of Breast Cancer

 

Room No. 9, 2F, ECEC

10:45-12:00

Track 1-6: Inflammatory Breast Cancer

08:30-09:45

Track 2-3: Molecular Diagnostics with Biomarkers

 

Room No. 11, 2F, ECEC

09:50-10:10

Track 3-4: Biomarkers in Breast Cancer Drug Discovery

10:25-12:05

Track 3-5: Targeting Nuclear and Hormone Receptor and Endocrine Therapy

08:30-12:05

Track 4-3: Anatomic Breast Imaging: Mammography, Tomosynthesis, Ultrasound, MRI

 

Room No. 16, 2F, ECEC

08:30-12:05

Track 4-4: Functional/Molecular Breast Imaging: PEM, GSBI, Optical Breast Imaging

 

Room No. 18, 2F, ECEC

April 26, 2010
(Monday) Afternoon

13:30-15:10

Track 1-1: Molecular Oncology on Breast Cancer (Part 2)

Room No. 7, 2F, ECEC

15:45-17:05

Track 4-2: Diagnostic Pathology, and Prognostics in Breast Cancer (Part II)

13:30-14:10

Track 1-7: Stem/Progenitor Cells

Room No. 9, 2F, ECEC

14:10-12:05

Track 1-8: Tumor Progression, Invasion and Metastasis

13:30-14:30

Track 1-9: Tumor Microenvironment and Breast Cancer

Room No. 11, 2F, ECEC

14:30-15:10

Track 3-6: Targeting Angiogenesis

15:25-15:45

Track 3-7: Targeting Farnesylation

15:45-17:05

Track 3-8: Targeting the MEK and the mTOR Pathway and other Novel Signaling Pathways

13:30-15:45

Track 4-5: Axillary Staging and Sentinel Nodes

Room No. 16, 2F, ECEC

15:45-17:05

Track 5-4: Advanced Targeted Breast Cancer Therapy

13:30-17:05

Track 4-6: Biopsy Techniques

Room No. 18, 2F, ECEC

April 27, 2010
(Tuesday) Morning

08:30-10:10

Track 1-10: Endocrinology and Breast Cancer

Room No. 7, 2F, ECEC

10:25-12:05

Track 1-11: Translational Research in Breast Cancer

08:30-10:10

Track 1-12: Growth Factors, Hormonal Factors and Receptors

Room No. 11, 2F, ECEC

10:25-11:40

Track 3-9: Targeting DNA Synthesis and Repair

11:40-12:05

Track 3-10: Targeting Ubiquitin Pathway

08:30-12:05

Track 1-4: Epidemiology, Genetics and Prevention(Part 2)

Room No. 12, 2F, ECEC

08: 30-08:55

Track 4-7: Circulating Markers

Room No. 16, 2F, ECEC

08:55-10:10

Track 5-5: Drug Resistance Management

10:25-11:15

Track 5-6: Antibody-Based Regimens

11:15-11:40

Track 5-8: Pain Management and Quality of Life

08:30-09:20

Track 3-11: Inhibiting Cell Growth

Room No. 18, 2F, ECEC

09:20-12:05

Track 5-7: Tailored Surgery for Early Breast Cancer and Surgical Management of Breast Cancer Liver Metastases

April 27, 2010
(Tuesday) Afternoon

13:30-14:50

Track 1-13: Animal Models and Novel Models

Room No. 7, 2F, ECEC

14:50-17:05

Track 1-14: Oncogenes/Tumor Suppressor Genes

13:30-17:05

Track 4-9: Screening and Detection

Room No. 11, 2F, ECEC

13:30-13:55

Track 3-12: Adjuvant, Neoadjuvant and Metastatic Hormonal Therapy

Room No. 16, 2F, ECEC

13:55-15:10

Track 3-13: SERMs, Aromatase Inhibitors, and SERDs

15:25-16:15

Track 4-8: Imaging-Guided Staging/Re-staging of Breast Cancer: PET, MRI

16:15-16:40

Track 5-9: nnovative Rational-Derived, Target-Based and Cytotoxic Therapies for Breast Cancer and Other Malignancies

16: 40-17:05

Track 5-10: Ductal Carcinoma in Situ: Patient Management and Systemic Treatment

April 28- April 29

 

Tour to Hangzhou and Wuzhen

 

 


© 2008-2010 All right reserved for BIT Conferences
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629